← Back
Data updated: Mar 10, 2026
PACO
Oncology
PACO is a generic drug manufacturer focused on Oncology.
1989
Since
5
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
LIDOCAINE HYDROCHLORIDE 2025-07-29
LIDOCAINE HYDROCHLORIDE 2025-04-02
LACTULOSE 2025-03-14
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (5)
Company Info
- First Approval
- 1989-06-30
- Latest
- 1989-06-30
- Applications
- 7